SLC2A3 and non-small cell lung carcinoma: In this paper, we investigated the clinical significance of 18-F-FDG PET-CT SUVmax, NLR, PLR, LMR, and expression of GLUT1 and GLUT3, which can easily be measured in clinical settings, among various tumor metabolic activity and systemic inflammation markers, in patients with NSCLC.